aMoon

Founded in 2016 and headquartered in Ra’anana, Israel, aMoon is a leading venture capital firm dedicated to transforming healthcare through groundbreaking science and technology. The firm was established by visionary entrepreneurs—including Marius Nacht (co-founder of Check Point Software) and Dr. Yair Schindel—and immediately set out to back moonshot innovations across digital health, life sciences, and medtech. aMoon operates globally, with a strategic presence in key innovation hubs.

With a multidisciplinary team exceeding 50 scientists, physicians, and investment specialists, aMoon invests across the full company lifecycle through its fund platforms: aMoon Velocity (early-stage), aMoon Growth (mid-to-late-stage), and public equity strategies. Their strength lies in bridging early-stage scientific breakthroughs with global commercialization pathways, backed by deep domain expertise and global networks.

Over the years, aMoon has built a strong track record—having made over 70 investments across healthcare and biotech, including recent deals in 2025, and backed notable exits like DayTwo and Omada’s IPO. Assets under management are estimated at over $1 billion, with some sources placing it between $750 million and $1.3 billion.